Activity of trioxaquine PA1259 in mice infected by Schistosoma mansoni = Activité de la trioxaquine PA1259 chez la souris infectée par Schistosoma mansoni - Université Pierre et Marie Curie Accéder directement au contenu
Article Dans Une Revue Comptes Rendus. Chimie Année : 2011

Activity of trioxaquine PA1259 in mice infected by Schistosoma mansoni = Activité de la trioxaquine PA1259 chez la souris infectée par Schistosoma mansoni

Résumé

Schistosomiasis is a chronic life-threatening parasitic disease concerning more than 200 million people in the World. Little attention has been paid to schistosomiasis over the last 30 years, and praziquantel is the only drug in use to control this disease. In the absence of a vaccine, there is a real need for new drugs in order both to improve the efficacy of the treatment and to delay the development of praziquantel resistant schistosomes. The present note reports the significant reduction of the worm burden after oral administration of trioxaquine PA1259 to mice infected by Schistosoma mansoni .

Dates et versions

halsde-00660907 , version 1 (18-01-2012)

Identifiants

Citer

Jérôme Boissier, Julien Portela, Vincent Pradines, F. Coslédan, A. Robert, et al.. Activity of trioxaquine PA1259 in mice infected by Schistosoma mansoni = Activité de la trioxaquine PA1259 chez la souris infectée par Schistosoma mansoni. Comptes Rendus. Chimie, 2011, 15, pp.75-78. ⟨10.1016/j.crci.2011.11.008⟩. ⟨halsde-00660907⟩
213 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More